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Abstract: Ultrasonography is the main imaging method for the
workup of thyroid nodules. However, interobserver agreement reported
for echogenicity and echotexture is quite low. The aim of this study was
to perform quantitative measurements of the degree of echogenicity and
heterogeneity of thyroid nodules, to develop an objective and repro-
ducible method to stratify these features to predict malignancy.
A retrospective study of patients undergoing ultrasonography-
guided fine-needle aspiration was performed in an University hospital
thyroid center. From January 2010 to October 2012, 839 consecutive
patients (908 nodules) underwent US-guided fine-needle aspiration. In a
single ultrasound image, 3 regions of interest (ROIs) were drawn: the
first including the nodule; the second including a portion of the adjacent
thyroid parenchyma; the third, the strap muscle. Histogram analysis was
performed, expressing the median, mean, and SD of the gray levels of
the pixels comprising each region. Echogenicity was expressed as a
ratio: the nodule/parenchyma, the nodule/muscle, and parenchyma/
muscle median gray ratios were calculated. The heterogeneity index
(HI) was calculated as the coefficient of variation of gray histogram for
each of the 3 ROIs. Cytology and histology reports were recorded.
Nodule/parenchyma median gray ratio was significantly lower
(more hypoechoic) in nodules found to be malignant (0.45 vs 0.61;
P¼ 0.002) and can be used as a continuous measure of hypoechogeni-
city (odds ratio [OR] 0.12; 95% confidence interval [CI] 0.03–0.49).
Using a cutoff derived from ROC curve analysis (<0.46), it showed a
substantial inter-rater agreement (k¼ 0.74), sensitivity of 56.7%
(95% CI 37.4–74.5%), specificity of 72.0% (67.8–75.9%), positive
likelihood ratio (LR) of 2.023 (1.434–2.852), and negative LR of 0.602
(0.398–0.910) in predicting malignancy (diagnostic odds ratio 3.36;
1.59–7.10). Parenchymal HI was associated with anti-thyroperoxidase
positivity (OR 19.69; 3.69–105.23). The nodule HI was significantly
higher in malignant nodules (0.73 vs 0.63; P¼ 0.03) and, if above the
0.60 cutoff, showed sensitivity of 76.7% (57.7–90.1%), specificity of
46.8% (42.3–51.4%), positive LR of 1.442 (1.164–1.786), and negativeandrini, MD, Carm MD,
talie Prinzi, MD, and Angela Fumarola, MD
HI) allows for an objective stratification of nodule echogenicity and
internal structure.
(Medicine 94(27):e1129)
Abbreviations: CI = confidence interval, CV = coefficient of
variation, DOR = diagnostic odds ratio, FNAC = fine-needle
aspiration cytology, HI = heterogeneity index, OR = odds ratio,
ROI = region of interest, US = ultrasonography.
INTRODUCTION
U ltrasonography (US) is the most widely accepted imagingmethod for the diagnosis and follow-up of diffuse thyroid
diseases and for the workup of focal lesions. Since its introduc-
tion, it has proven to be a cornerstone in the diagnostic
algorithm of thyroid nodules because of its low cost and
widespread availability. Thyroid echogenicity reflects the
follicular structure because the interface between thyrocytes
and colloid has a high acoustic impedance. Diffuse or focal
variations of normal gland structure cause an alteration of this
pattern. Nodule echogenicity is dependent on the composition
and cellularity of the nodule.1 Subjective visual analysis is the
first-line method to assess thyroid nodules, although it is limited
by inter-observer variability and observer experience, with a
consequently low reproducibility of results. Echogenicity of the
gland is usually compared with the strap muscles, and echo-
genicity of the nodule is compared with the surrounding par-
enchyma, allowing definitions like ‘‘hypo,’’ ‘‘hyper,’’ or
‘‘isoechogenic’’ tissue. Marked hypoechogenicity is usually
defined as relative hypoechogenicity compared with the sur-
rounding muscles (mm. sternohyoidei and sternothyreoidei).2,3
However, neither the AIUM Guidance4 nor a recent multi-
disciplinary consensus statement5 describes how to assess
echogenicity (with respect to muscles or surrounding thyroid
tissue). According to a recent report,6 hypoechogenicity and
marked hypoechogenicity showed an odds ratio (OR) for thyr-
oid malignancy of 2.60 and 6.81, respectively. However, the
comparison of different tissues is difficult and leads to inevi-
table variability among operators. Furthermore, thyroid US is
performed and interpreted by a number of different specialists in
various settings and with different training (endocrinologists,
radiologists, otolaryngologist, and head and neck surgeons).5 In
fact, fair inter-observer agreement was recently reported for
hypoechogenicity (k¼ 0.34).7 These findings were indirectly
confirmed by a meta-analysis, showing that hypoechogenicity
has a diagnostic odds ratio (DOR) for malignancy of 4.5, with a
significant heterogeneity between studies (inconsistency index
I2 88%) and no distinction between various degrees of echo-analysis is the second-line method,
more objective and reproducible results.
gray-scale analysis was proposed to
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Grani et al Medicine  Volume 94, Number 27, July 2015eliminate the subjective component of the evaluation, allowing
quantitative determination of echogenicity, independently from
the visual impression of the investigator, but it was applied only
for the parenchymal assessment.2,3,9,10 In the present study, we
have performed a gray-scale histogram analysis of thyroid
echogenicity in comparison with neck muscles, as well as
nodule echogenicity in comparison with surrounding parench-
yma. Through this procedure, we aim to perform – for the first
time – a quantitative measurement of thyroid nodule echogeni-
city and echotexture (the distribution of echoes), obtaining a
1 paent up 10 paents
FIGURE 1. Flow chart of patient inclusion and data collection.numerical and objective estimate of the degree of hypoecho-
histology (20 cases), two consecutive FNACs (272), or a singlegenicity and homogeneity and evaluate their diagnostic
accuracy in predicting the risk of nodule malignancy.
MATERIALS AND METHODS
The institutional review board approved this retrospective
study and did not require patient approval or informed consent
for the review of patient images and records. All patients gave
written informed consent for the ultrasonography-guided fine-
needle aspiration cytology (FNAC).
From January 2010 to October 2012, 839 consecutive
patients (908 nodules) underwent US-guided FNAC at the
Thyroid Center of our Department (Figure 1). The patients
were aged 55.92 13.55 years (meanSD) and all resided in
Central Italy, an area of mild–moderate iodine deficiency.
There was no difference in age between male and female
patients: 161 men were aged 57.12 13.35 years, whereas
678 women were aged 55.63 13.59 years (P¼ 0.21). All
patients had at least 1 discrete nodular lesion of the thyroid
or a multinodular goiter. Nodules were selected according to
published international guidelines at the time of sampling,11,12
but without any established volume cutoff.
Anti-thyroperoxidase (anti-TPO) antibodies were measured
using radioimmunoassay (RIA, BRAHMS Diagnostica, Berlin,
Germany) and were considered positive if found to be above
the cutoff point set by the laboratory (>50U/mL).
US was performed using a Toshiba Aplio XV device
equipped with a linear high-frequency transducer. Examinations
were performed by 1 of 10 endocrinologists with 3 to 5 years of
experience in thyroid US. US features were prospectively
recorded (diameters, echogenicity, echotexture, and vascularity)
into an electronic database for clinical use. Echogenicity was
subjectively classified as hyper-, iso-, hypoechogenic (when a
nodule showed hyper-, iso-, or hypoechogenicity compared
2 | www.md-journal.comwith the normal thyroid gland), iso-hypoechogenic (slight
hypoechogenicity), or heterogeneous (hypo- or iso-echogeni-
city with a marked heterogeneous echotexture).
US-assisted FNAC was carried out through aspiration by
using 23–25 gauge needles attached to a 10-mL syringe. The
US transducer was placed to center the nodule with a transverse,
free-hand approach, and the needle was inserted right in the
middle of the transducer. The tip was localized as a bright point,
when possible. One to 3 aspirations were performed on each
nodule. In case of solid/cystic mixed nodule, a sample of the
solid component was drawn.
The first smear was air-dried and stained using the May-
Grunwald-Giemsa method. The remaining smears were fixed
with Bio-fix (Bioptica, Milan, Italy), and stained with hema-
toxylin–eosin (HE). Cytology results were reported in 5
categories, as follows, according to the Thyroid Cytology Italian
Consensus SIAPEC-IAP13: non-diagnostic, benign, indetermi-
nate, probably malignant, and positive for malignant cells.
Malignancy was confirmed by histology (30 cases; 2 medullary
thyroid cancer, 28 papillary thyroid cancer) and ruled out by
2 paents 6 paentsFNAC with follow-up (197). Two patients had an indeterminate
cytology report, but refused surgery and were excluded.
Image Analysis
The images were stored as 8-bit (28¼ 0–255 gray-scale
levels) JPEG images, 716 537 pixels, and gray-scale mode.
The grey histogram ranged from 0 (black pixels) to 255 (white
pixels).
In each image, 2 regions of interest (ROIs) were manually
drawn: the first included the entire nodule (excluding hypoe-
chogenic halo, if present) and the second, a portion of the
adjacent thyroid parenchyma with no focal lesions. The ROIs
were drawn in the same image, having the same shape and
number of pixels, avoiding blood vessels and artifacts. A third
ROI included the strap muscle, having the same number of
pixels, but different shape. Histogram analysis was then per-
formed and echo intensity was measured in gray-scale levels,
expressing the median, mean, and standard deviation (SD) of
the gray-scale levels of the pixels included in each ROI
(Figure 2). The echogenic appearance of the thyroid gland
varies with the adjustment of various instrument settings (gain,
depth range, dynamic range). To overcome the need of standard
operating conditions, echogenicity was expressed as a ratio: the
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
operator (GG), without access to cytology and histology final
tinuous measurements.15 All tests used a 2-sided a of 0.05. Data
Medicine  Volume 94, Number 27, July 2015nodule/parenchyma median grey ratio, nodule/muscle median
grey ratio, and parenchyma/muscle median grey ratio were then
calculated. The heterogeneity index (HI) was calculated as the
coefficient of variation (CV) of gray histogram (SD/mean) for
each of the 3 ROIs (nodule HI, parenchyma HI, and muscle HI).
Calcifications and echogenic foci of colloid were not excluded,
to allow them to influence the HI. However, they unlikely
influenced the median grey ratios because the median is slightly
FIGURE 2. Drawing regions of interest (ROIs) to include nodule
(A) and parenchyma (B).modified by a small number of bright pixels.
Nine nodules were excluded because of entirely cystic
content, 203 were lacking a properly saved image, and 175 did
TABLE 1. Differences Between Males and Females (Mann–Whitn
Males
Median Interquart
Nodule/parenchyma median gray ratio 0.58 (0.43–
Parenchyma/muscle median gray ratio 2.14 (1.26–
Nodule/muscle median gray ratio 1.20 (0.88–
Nodule HI 0.61 (0.48–
Parenchyma HI 0.35 (0.29–
Muscle HI 0.57 (0.46–
HI¼ heterogeneity index.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.not have a sufficient amount of surrounding parenchyma. Five
hundred twenty-one images of nodules were finally evaluated,
coming from 476 patients (aged 55.37 13.56 years; 91 males
aged 55.67 14.27 years, and 385 females aged 55.30 13.40
years; P¼ 0.81).
Image analysis was performed retrospectively by a single
Grey-Scale Analysis for Thyroid Nodulesdata. A subsequent analysis was independently performed by
another author (AF), to evaluate inter-rater agreement.
Statistical Analysis
The distributions of heterogeneity index and median gray
ratios were not normal (Shapiro–Wilk test). Comparisons were
performed using the Mann–Whitney U (between 2 groups) and
Kruskal–Wallis tests (>2 groups). Categorical variables were
compared using Fisher exact or Pearson chi-square test. Esti-
mates of diagnostic accuracy were reported as sensitivity,
specificity, likelihood ratio, and DOR with 95% confidence
intervals (CIs). The DOR measures the discriminative power of
a diagnostic test and reflects the test’s performance compared
with the reference standard. The value ranges from 0 to infinity,
with higher values indicating better performance. The sensi-
tivities and specificities were compared using the exact McNe-
mar test. The optimal cutoff value for the nodule/parenchyma
ratio and nodule HI was calculated using receiver-operating
characteristic (ROC) analysis. Odds ratios (ORs) and 95% CIs
were also calculated. Interobserver variability for evaluation of
echogenicity and for the measurement of the ratios (considering
the nodule/parenchyma median gray ratio and nodule HI quali-
tatively as a binary variable) between the 2 observers was
defined by using Cohen kappa statistic.14 The Bland–Altman
technique was used to determine the agreement between con-analysis was performed using IBM SPSS Statistics 20.0 (IBM
Corp, Armonk, NY) and Microsoft Office Excel 2007.
RESULTS
Age- and Sex-Related Differences
No difference was recorded between males and females in
relation to nodule/parenchyma median gray ratio, parenchyma
HIs, and nodule HIs. Nodule/muscle median gray ratio, par-
enchyma/muscle median gray ratio, and muscle HIs were
significantly higher in males than in females (Table 1). No
significant difference was recorded between nodules in patients
younger and older than 45 years (Table 2).
ey Test)
Females
ile Range Median Interquartile Range P
0.97) 0.61 (0.44–0.86) 0.79
3.12) 1.47 (1.04–2.06) <0.001
2.00) 0.96 (0.60–1.43) <0.001
0.81) 0.65 (0.49–0.90) 0.40
0.43) 0.35 (0.30–0.42) 0.85
0.81) 0.53 (0.42–0.67) 0.02
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TABLE 2. Age-related Differences (Mann–Whitney Test)
Age 45 Years Age >45 Years
Median Interquartile Range Median Interquartile Range P
Nodule/parenchyma median gray ratio 0.58 (0.43–0.86) 0.64 (0.43–0.89) 0.23
Parenchyma/muscle median gray ratio 1.63 (1.14–2.56) 1.53 (1.04–2.25) 0.58
Nodule/muscle median gray ratio 1.04 (0.58–1.64) 1.00 (0.64–1.50) 0.14
Nodule HI 0.63 (0.48–0.88) 0.64 (0.48–0.90) 0.85
Parenchyma HI 0.34 (0.29–0.42) 0.35 (0.30–0.42) 0.91
Muscle HI 0.55 (0.42–0.67) 0.54 (0.42–0.68) 0.32
Grani et al Medicine  Volume 94, Number 27, July 2015Median Gray Ratios
Nodule/parenchyma median gray ratios were significantly
different between mixed content and solid (iso-, or hypoechoic)
nodules (P< 0.001 andP¼ 0.004 respectively) and, among solid
nodules, between iso- and hypoechoic nodules (P< 0.001),
between heterogeneous and hypoechoic nodules (p¼ 0.02),
and between heterogeneous and isoechoic nodules (P¼ 0.001)
(Figure 3, Table 3). No significant difference was recorded
between iso-hypoechoic nodules, isoechoic nodules, and hetero-
geneous nodules. Ratio was significantly lower (ie, more hypoe-
choic) in nodules found to be malignant (Table 4; P¼ 0.002).
An ROC curve analysis was performed to establish a
diagnostic cutoff (area under the curve [AUC] 0.67). A cutoff
HI¼ heterogeneity index.of 0.46 reaches sensitivity of 56.7% (95% CI 37.4%–74.5%)
and specificity of 72.0% (95% CI 67.8%–75.9%) in predicting
malignancy (DOR 3.36; 95% CI 1.59–7.10; Table 5). To rule
FIGURE 3. Nodule/parenchyma median gray ratio according to subj
4 | www.md-journal.comout liquid nodules, a double cutoff should be used (ratio >0.20
and<0.46), that achieves sensitivity of 53.3% (95% CI 34.3%–
71.7%), specificity of 77.1% (95% CI 73.1%–80.7%), and
DOR 3.85 (95% CI 1.82–8.12).
A logistic regression analysis was performed to demon-
strate that nodule/parenchyma median gray ratio can be used as
a continuous measure of hypoechogenicity and – indirectly – of
risk of malignancy (OR 0.12; 95% CI 0.03–0.49; P¼ 0.003).
Nodule/muscle median gray ratio was analyzed stratified
by sex, as it is influenced by sex (Table 1). Only in females, it
turned out to be lower in malignant nodules (0.75, I.R. 0.42–
0.83) than in benign ones (1.00, I.R. 0.62–1.44, P¼ 0.008).
HI
To evaluate the ability of the proposed HI to evaluate the
heterogeneous echotexture, the parenchymal HI was evaluated
ective description of the nodules.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Nodule/Parenchyma Median Gray Ratios and Nodule HI According to Subjective Description of the Nodules
Nodule/Parenchyma Median Gray Ratio Nodule HI
Subjective Description Median Interquartile Range Median Interquartile Range
Solid
Isoechogenic 0.97 (0.78–1.23) 0.47 (0.40–0.62)
Iso-hypoechogenic 0.62 (0.43–1.11) 0.59 (0.46–0.69)
Heterogeneous 0.65 (0.48–0.87) 0.56 (0.49–0.83)
Hypoechogenic 0.50 (0.38–0.71) 0.73 (0.52–1.13)
Mixed solid/liquid 0.61 (0.47–0.89) 0.69 (0.54–0.9)
Mostly cystic 0.24 (0.05–0.28) 2.09 (1.42–2.09)
Medicine  Volume 94, Number 27, July 2015 Grey-Scale Analysis for Thyroid Nodulesin patients with or without anti-TPO antibodies. The median
parenchymal HI was 0.38 (I.R. 0.31–0.44) in the positive anti-
TPO group and 0.34 (I.R. 0.29–0.41) in the negative group
(P¼ 0.007). A logistic regression analysis showed that par-
enchymal HI is strongly associated with anti-TPO positivity
(OR 19.69; 95% CI 3.69–105.23; P< 0.001).
However, no relation was found between subjective
description of heterogeneity and nodular HI. In particular, no
significant difference was recorded between nodules labeled
‘‘heterogeneous’’ and those identified in any of the other
categories except ‘‘isoechogenic’’ (P< 0.001). The nodular
HI was not a significant predictor of malignance according
to logistic regression analysis. However, it was significantly
higher in malignant nodules (Table 4) and, with a cutoff of 0.60,
HI¼ heterogeneity index.derived from the ROC curve analysis; it achieves a sensitivity of
76.7% (95%CI 57.7%–90.1%) and a specificity of 46.8% (95%
CI 42.3%–51.4%).
Inter-Rater Agreement
The inter-rater agreement was fair (k¼ 0.40) for subjective
assessment of hypoechogenicity, whereas it was substantial for
the nodule/parenchyma grey ratio (k¼ 0.74 with a single cutoff,
k¼ 0.64 with a double cutoff). A Bland-Altman plot is reported
in Figure 4.
DISCUSSION
Thyroid nodules are very common and there is a large pool
of asymptomatic people with nodules in the general population.
Depending on the population studied and the method of detec-
tion used, the prevalence of thyroid nodules ranges from 5% to
60%.8 The probability that these nodules will be discovered by a
widely available, economic, and harmless method, such as
TABLE 4. Nodule/Parenchyma Median Gray Ratio and Nodule H
Nodule/Parenchyma Median Gra
Final Diagnosis Median Interquartile
Benign 0.61 (0.44–0.
Malignant 0.45 (0.36–0.
Mann–Whitney test P¼ 0.002
HI¼ heterogeneity index.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.thyroid US, is therefore increasing. Although the majority of
these thyroid nodules are benign, the frequency of malignancy
is 8% to 15%.16 US is the best diagnostic tool to date in the
initial work-up of thyroid nodules, to avoid unnecessary surgi-
cal interventions. However, there is significant uncertainty
surrounding the diagnostic accuracy of several of the features
analyzed during the US evaluation.8,17,18 This uncertainty is
due, to some degree, to the operator-dependence of the US
techniques and the lack of agreement at reporting these fea-
tures.5 The interobserver agreement seems to be relatively good,
according to recent reports7,19; however, only a slight agree-
ment was reported for echogenicity7 and echotexture.19 The
former, in particular, is a major suspicious US feature. Further-
more, the terminology used by ultrasonologists is ambiguous at
times and various nomenclatures are available for the same
finding. For this reason, a consensus reporting protocol was
recently proposed, including the description of internal archi-
tecture and echogenicity of the nodules.5 However, no indica-
tion was given about the assessment and classification of
echogenicity (eg, the terms ‘‘hypoechoic’’ and ‘‘profoundly
hypoechoic’’ were suggested, without any guidance on con-
sistent interpretation). In a recent population-based study,
echogenicity did not turn out to be a significant predictor of
malignancy, but it was quite arbitrarily classified in ‘‘hypoe-
choic to strap,’’ ‘‘isoechoic or hyperechoic to strap,’’ ‘‘iso-
echoic to thyroid,’’ and ‘‘hyperechoic to thyroid.’’
In the absence of accurate predictors of malignancy, many
of the nodules will still require FNAC, which is expensive and
often challenging, as in the case of indeterminate and non-
diagnostic results. On the contrary, US features should serve as
a guide for determining the depth of nodule evaluation.
Some authors have proposed the recognition of complex
patterns rather than single features to identify suspicious
I According to Final Diagnosis
y Ratio Nodule HI
Range Median Interquartile Range
91) 0.63 (0.48–0.89)
68) 0.73 (0.59–1.16)
P¼ 0.033
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6 | www.md-journal.comnodules. To standardize this approach and to avoid unnecessary
biopsies, several models were designed, for example, Thyroid
Imaging Reporting and Data System (TIRADS),20–23 similar to
the Breast Imaging Reporting and Data System (BIRADS), used
to standardize the interpretation of breast imaging. However,
some of these are difficult to apply in clinical practice and rely
on arbitrary evaluation of US features by the observer, even
when employing complex equations.
In this study, we developed a method to perform a quan-
titative measurement of thyroid echogenicity (ie, the median
gray ratio) and echotexture (ie, the heterogeneity index, calcu-
lated as CV of grey-levels histogram), using adimensional
values and avoiding the need for fixed US operating conditions
(such as depth and gain).
No significant difference was recorded (using numerical
estimates of echogenicity) between iso-hypoechogenic nodules
and hypoechogenic, iso-hypoechogenic and isoechogenic, and
iso-hypoechogenic and heterogeneous nodules, thereby show-
ing a substantial overlap across these subjective descriptions,
which are confusing for the clinician. However, a real, coun-
table difference was observed between hypoechogenic and
isoechogenic nodules. In particular, nodules with a nodule/
parenchyma gray ratio <0.46 (ie, hypoechogenic) have an
OR for malignancy of 3.36. Moreover, our data showed that
the appearance and echogenicity of neck muscles are different
in males and females, thus demonstrating that the traditional
definition of markedly hypoechogenic nodules (hypoechogenic
with respect to strap muscles) is not easily reproducible. Indeed,
a numerical evaluation of hypoechogenicity (nodule/parench-
yma grey ratio) is able to precisely quantify the degree of
hypoechogenicity and estimate the risk of malignancy related to
this particular feature, without comparisons with different
tissues, with a substantial interobserver agreement (k¼ 0.74)
and diagnostic accuracy.
The heterogeneity index was recently proposed by Wakita
et al10; however, they evaluated the US intensities along a
straight line, a method not applicable for evaluation of focal
lesions. We have calculated HI for thyroid parenchyma and
nodules, with a different method. The parenchyma HI showed
the ability to recognize thyroid autoimmunity and seems to be a
promising approach, whereas the nodule HI was increased in
malignant nodules.
Our study had several limitations. First, selection bias may
have existed in recruiting patients to include in the study
because all nodules were suspicious to a certain extent and
submitted to FNAC. However, our institution policy is to
perform FNAC also in case of a single risk factor, be it clinical
(familiarity, history of irradiation) or sonographic (ill-defined
margins, microcalcification, hypoechogenicity). Accordingly,
the overall malignancy rate of this cohort is relatively low
(5.76%) if compared with other reports. Furthermore, the
sample was insufficient to evaluate the diagnostic value of this
method in the different histotypes of thyroid cancer and the
reproducibility of this technique with different US equipments
is to be confirmed.
In conclusion, we demonstrated that gray-scale analysis is
applicable to the US evaluation of thyroid nodules in clinical
practice, rapidly and without the need for fixed operating
conditions. Evaluation of nodule echogenicity and echotexture
according to a numerical estimate (nodule/parenchyma median
grey ratio and nodule HI) allows for a practical and objective
Medicine  Volume 94, Number 27, July 2015stratification of nodule echogenicity and internal structure that
could also be included in new TIRADS models. Adoption of
uniform standards for the reporting of thyroid US could
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
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Medicine  Volume 94, Number 27, July 2015 Grey-Scale Analysis for Thyroid Nodulesprobably be useful in limiting unnecessary diagnostic pro-
cedures (repeated FNAC, core-needle biopsy) or treatments.
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